Regulus Therapeutics Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RGLS has 69.23 million shares outstanding. The number of shares has increased by 199.52% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 69.23M |
| Shares Change (YoY) | +199.52% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 2.02% |
| Owned by Institutions (%) | 60.81% |
| Float | 62.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.31, with a Debt / Equity ratio of 0.02.
| Current Ratio | 16.31 |
| Quick Ratio | 14.87 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -550.55 |
Financial Efficiency
Return on equity (ROE) is -53.82% and return on invested capital (ROIC) is -35.91%.
| Return on Equity (ROE) | -53.82% |
| Return on Assets (ROA) | -34.23% |
| Return on Invested Capital (ROIC) | -35.91% |
| Return on Capital Employed (ROCE) | -73.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 34 |
| Asset Turnover | n/a |
| Inventory Turnover | 11.15 |
Taxes
In the past 12 months, RGLS has paid $1,000 in taxes.
| Income Tax | 1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +225.10% in the last 52 weeks. The beta is 0.37, so RGLS's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +225.10% |
| 50-Day Moving Average | 6.65 |
| 200-Day Moving Average | 2.76 |
| Relative Strength Index (RSI) | 66.62 |
| Average Volume (20 Days) | 2,586,472 |
Short Selling Information
The latest short interest is 2.09 million, so 3.02% of the outstanding shares have been sold short.
| Short Interest | 2.09M |
| Short Previous Month | 1.91M |
| Short % of Shares Out | 3.02% |
| Short % of Float | 3.32% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | -36.15M |
| Operating Income | -51.75M |
| Pretax Income | -35.39M |
| Net Income | -47.52M |
| EBITDA | -51.40M |
| EBIT | -51.75M |
| Earnings Per Share (EPS) | -$0.72 |
Balance Sheet
The company has $65.37 million in cash and $1.40 million in debt, giving a net cash position of $63.97 million or $0.92 per share.
| Cash & Cash Equivalents | 65.37M |
| Total Debt | 1.40M |
| Net Cash | 63.97M |
| Net Cash Per Share | $0.92 |
| Equity (Book Value) | 69.03M |
| Book Value Per Share | 1.04 |
| Working Capital | 67.30M |
Cash Flow
In the last 12 months, operating cash flow was -$43.54 million and capital expenditures -$111,000, giving a free cash flow of -$43.66 million.
| Operating Cash Flow | -43.54M |
| Capital Expenditures | -111,000 |
| Free Cash Flow | -43.66M |
| FCF Per Share | -$0.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RGLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -199.52% |
| Shareholder Yield | -199.52% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for RGLS is $8.50, which is 4.17% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.50 |
| Price Target Difference | 4.17% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 29, 2022. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jun 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |